Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Research and Markets
Drug delivery industry stands to benefit from patent expirations
June 23rd, 2006
A new report by Research and Markets assesses the current state of the drug delivery industry. According to The Global Drug Delivery Market - Research Trends and Market Outlook, the drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug delivery companies not only stand to benefit from patent expiry by providing their reformulation services to pharmaceutical companies, but also by producing their own versions of branded products with improved delivery mechanisms. Thus, post patent expiry sales can be switched from the ethical manufacturer to the drug delivery...
Source: Biotech Law Weekly (2006-06-23)
|
